286 related articles for article (PubMed ID: 32840210)
21. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
22. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.
Sreekumar A; Roarty K; Rosen JM
Endocr Relat Cancer; 2015 Dec; 22(6):T161-76. PubMed ID: 26206777
[TBL] [Abstract][Full Text] [Related]
23. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.
Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H
Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker.
Lei B; Zhang XY; Zhou JP; Mu GN; Li YW; Zhang YX; Pang D
Tumour Biol; 2016 Nov; 37(11):14757-14764. PubMed ID: 27629143
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.
Dravis C; Chung CY; Lytle NK; Herrera-Valdez J; Luna G; Trejo CL; Reya T; Wahl GM
Cancer Cell; 2018 Sep; 34(3):466-482.e6. PubMed ID: 30174241
[TBL] [Abstract][Full Text] [Related]
26. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
[TBL] [Abstract][Full Text] [Related]
27. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
28. Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.
McCune K; Mehta R; Thorat MA; Badve S; Nakshatri H
Oncol Rep; 2010 Nov; 24(5):1233-9. PubMed ID: 20878115
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
30. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in
Hu L; Su L; Cheng H; Mo C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Zhang J; Xie Y
Cancer Res; 2021 May; 81(10):2600-2611. PubMed ID: 33727227
[TBL] [Abstract][Full Text] [Related]
31. Role of epithelial stem/progenitor cells in mammary cancer.
Bruno RD; Smith GH
Gene Expr; 2011; 15(3):133-40. PubMed ID: 22268295
[TBL] [Abstract][Full Text] [Related]
32. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
34. Dietary chemopreventative benzyl isothiocyanate inhibits breast cancer stem cells in vitro and in vivo.
Kim SH; Sehrawat A; Singh SV
Cancer Prev Res (Phila); 2013 Aug; 6(8):782-90. PubMed ID: 23661606
[TBL] [Abstract][Full Text] [Related]
35. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
[TBL] [Abstract][Full Text] [Related]
36. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
37. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer stem cells and tumor suppressor genes.
Hwang-Verslues WW; Chang KJ; Lee EY; Lee WH
J Formos Med Assoc; 2008 Oct; 107(10):751-66. PubMed ID: 18926942
[TBL] [Abstract][Full Text] [Related]
39. Distinct populations of tumor-initiating cells derived from a tumor generated by rat mammary cancer stem cells.
Zucchi I; Astigiano S; Bertalot G; Sanzone S; Cocola C; Pelucchi P; Bertoli G; Stehling M; Barbieri O; Albertini A; Schöler HR; Neel BG; Reinbold RA; Dulbecco R
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16940-5. PubMed ID: 18957543
[TBL] [Abstract][Full Text] [Related]
40. Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics.
Thong T; Wang Y; Brooks MD; Lee CT; Scott C; Balzano L; Wicha MS; Colacino JA
Front Cell Dev Biol; 2020; 8():288. PubMed ID: 32457901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
